Janus Henderson Group’s IRulya Therapeutics IRLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$53.2M Buy
+1,714,957
New +$45.7M 0.02% 408

Other funds holding IRLA

Janus Henderson Group's IRLA Position: Q3 2026 in Review

Janus Henderson Group opened a new position in IRulya Therapeutics (IRLA) in Q3 2026: 1,714,957 shares worth $53.2M. The stake represents 0.02% of the portfolio and ranks #408 among its holdings.

33 funds tracked by Wall St. Rank hold IRLA as of Q3 2026.

  • Janus Henderson Group held 1,714,957 shares of IRulya Therapeutics worth $53.2M as of Q3 2026.
  • IRulya Therapeutics was a new Janus Henderson Group position in Q3 2026.
  • IRulya Therapeutics made up 0.02% of Janus Henderson Group's portfolio in Q3 2026, its #408 holding.
  • 33 funds tracked by Wall St. Rank held IRulya Therapeutics as of Q3 2026.

Based on Janus Henderson Group's 13F filing for Q3 2026, filed 16 Nov 2026.